Skip to main content
Signal8

Bellon Christine

SEC insider (Form 3/4/5 filer). CIK 0001963878. Chief Legal Officer at Beam Therapeutics Inc. (BEAM). 17 reported Form 4/5 transactions since Sep 2024; latest on Apr 1, 2026. Located in CAMBRIDGE, MA.

Companies Bellon Christine has filed insider reports for

  • Beam Therapeutics Inc. (BEAM): Officer, Chief Legal Officer
Bellon Christine profile photo

Bellon Christine

CIK: 0001963878

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)11 (64.7%)

Position reduction

Option Exercises (M)2 (11.8%)

Derivative conversions

Awards (A)4 (23.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Beam Therapeutics Inc. logo
BEAM

Beam Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (17 total)

  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Apr 1, 2026
    Sale
    Direct
    6K shares at avg. $24.58$146K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Mar 31, 2026
    Award
    Direct
    20K shares-
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jan 31, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    40K shares-
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jan 22, 2026
    Sale
    Direct
    1.4K shares at avg. $34.00$47K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jan 15, 2026
    Sale
    Direct
    559 shares at avg. $35.40$20K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jan 15, 2026
    Sale
    Direct
    16K shares at avg. $34.72$554K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jan 15, 2026
    Sale
    Direct
    2.1K shares at avg. $33.62$71K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Dec 31, 2025
    Sale
    Direct
    1.3K shares at avg. $27.10$34K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Oct 1, 2025
    Sale
    Direct
    373 shares at avg. $24.53$9K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Apr 1, 2025
    Sale
    Direct
    5.7K shares at avg. $18.35$104K

1-10 of 17